Meanwhile, a series of compounds exhibited an effect on cataracts by modulating the PI3K-Akt signaling pathway, such as alkylphosphocholine erufosine [64], quercetin [65], and andrographolide [66]. The gene discussed is AKT1; the disease is cataract.